Hematopoietic growth factors in cancer chemotherapy.
Lieschke
G J
GJ
Whitehead Institute for Biomedical Research, Cambridge, MA, USA.
Foote
M
M
Morstyn
G
G
D000740:Anemia / Q000628:therapy; D000818:Animals; D000970:Antineoplastic Agents / Q000009:adverse effects*; D016026:Bone Marrow Transplantation; D004921:Erythropoietin / Q000627:therapeutic use; D005334:Fever / Q000628:therapy; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000627:therapeutic use; D016298:Hematopoietic Cell Growth Factors / Q000627:therapeutic use*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*; D009503:Neutropenia / Q000628:therapy; D011994:Recombinant Proteins; D013280:Stomatitis / Q000628:therapy
D000970:Antineoplastic Agents; D016298:Hematopoietic Cell Growth Factors; D011994:Recombinant Proteins; D004921:Erythropoietin; D016179:Granulocyte Colony-Stimulating Factor; D016178:Granulocyte-Macrophage Colony-Stimulating Factor